Navigation Links
Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
Date:6/28/2012

(PRWEB) June 28, 2012

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provide free online informational resources that deal with the potential dangers of using certain prescription medications, hereby alerts the public that an Actos bladder cancer lawsuit has been filed in Louisiana by a woman who alleges that her use of this diabetes medication led to her contracting bladder cancer.

Specifically, the case has been assigned a case number of 6:12-cv-1701 and it names several defendants in the action. These defendants include Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Co. The case was filed on June 14th in the U.S. District Court for the Western District of Louisiana and is assigned to Judge Rebecca Doherty.

This Actos bladder cancer lawsuit alleges that the plaintiff used Actos between the years of 2004 and 2007. The plaintiff was diagnosed with bladder cancer in 2006, and she alleges that the prolonged use of Actos is what led to this diagnosis. As a result of this diagnosis, the plaintiff alleges that she has incurred damages that include past and future medical costs, past and future pain and suffering, past and future emotional distress and the loss of companionship with her spouse.

Actos is a diabetes medication that is prescribed for people to help them treat their symptoms associated with type 2 diabetes, and in recent years the medication has been banned in both France and Germany and the United States Food and Drug Administration has required warnings to be published on the labels of this medication that alert its users of the potential risks involving bladder cancer for those who use it for a prolonged period of time.

About the Consumer Justice Foundation    

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

Read the full story at http://www.prweb.com/releases/2012/6/prweb9650623.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Chemo + Radiation Best for Bladder Cancer, Study Finds
4. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
5. Protein RAL associated with aggressive characteristics in prostate, bladder and skin cancers
6. Study Ties Secondhand Smoke to Bladder Irritation in Kids
7. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
8. Surgical sling reduces risk of weakened bladder control after prolapse surgery, U-M study says
9. Study Suggests Vaccine May Help Kids With Brain Cancer
10. New Stool Test Might Aid in Early Detection of Colon Cancer
11. Study reveals how cancer drug causes diabetic-like state
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... , ... April 26, 2017 , ... ... to improve the profitability of ready-to-drink, high-protein beverages by helping beverage manufacturers more ... to dairy proteins, providing direct cost savings as well as more stable pricing ...
(Date:4/25/2017)... ... 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... physical therapy provider for Derby City CrossFit, effective immediately. , In addition to ... and effectively as possible, ProRehab’s sports physical therapists will work with athletes to ...
(Date:4/25/2017)... ... April 25, 2017 , ... The doctors at Wall Centre Dental are now ... fear and require sedation to receive dental care. The doctors offer three treatment options ... hygienic cleanings to oral surgery, at their dental office in Vancouver. Wall Centre Dental ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America ... a reputable physician in their area, announces the launch of a new and proprietary ... who are looking for reputable physicians to help them with back or neck pain ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South Florida ... report in the May issue of Consumer Reports focused on heart health. , ... achieved during and after coronary bypass and aortic valve replacement procedures. , Consumer ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... -- Halo Labs announces the launch of a novel ... the Horizon at PEGS 2017 in Boston ... sub visible particulate matter in biopharmaceutical samples to enable ... as candidate selection and pre-formulation. Halo Labs ... Elion Labs for system validation. "We are ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: